Please login to the form below

Not currently logged in
Email:
Password:

bupropion

This page shows the latest bupropion news and features for those working in and with pharma, biotech and healthcare.

Pfizer’s Champix and GSK’s Zyban cleared of causing neuropsychiatric side effects

Pfizer’s Champix and GSK’s Zyban cleared of causing neuropsychiatric side effects

The EAGLES study - published in The Lancet - backed the safety and efficacy of Pfizer's Chantix/Champix (varenicline) and GlaxoSmithKline's Zyban (bupropion) as well as nicotine replacement therapies in helping

Latest news

More from news
Approximately 4 fully matching, plus 30 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics